Browse by Journal Title

Article

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese, R. and Battaglini, M. and Prados, F. and Bianchi, A. and Haider, L. and Jacob, A. and Palace, J. and Messina, S. and Paul, F. and Wuerfel, J. and Marignier, R. and Durand-Dubief, F. and de Medeiros Rimkus, C. and Callegaro, D. and Sato, D.K. and Filippi, M. and Rocca, M.A. and Cacciaguerra, L. and Rovira, A. and Sastre-Garriga, J. and Arrambide, G. and Liu, Y. and Duan, Y. and Gasperini, C. and Tortorella, C. and Ruggieri, S. and Amato, M.P. and Ulivelli, M. and Groppa, S. and Grothe, M. and Llufriu, S. and Sepulveda, M. and Lukas, C. and Bellenberg, B. and Schneider, R. and Sowa, P. and Celius, E.G. and Proebstel, A.K. and Yaldizli, Ö. and Müller, J. and Stankoff, B. and Bodini, B. and Carmisciano, L. and Sormani, M.P. and Barkhof, F. and De Stefano, N. and Ciccarelli, O.
Brain 146 (6): 2489-2501. June 2023

Parallel in-depth analysis of repeat expansions in ataxia patients by long-read sequencing.
Erdmann, H. and Schöberl, F. and Giurgiu, M. and Leal Silva, R.M. and Scholz, V. and Scharf, F. and Wendlandt, M. and Kleinle, S. and Deschauer, M. and Nübling, G. and Heide, W. and Babacan, S.S. and Schneider, C. and Neuhann, T. and Hahn, K. and Schoser, B. and Holinski-Feder, E. and Wolf, D.A. and Abicht, A.
Brain 146 (5): 1831-1843. May 2023

The genomic landscape across 474 surgically accessible epileptogenic human brain lesions.
López-Rivera, J.A. and Leu, C. and Macnee, M. and Khoury, J. and Hoffmann, L. and Coras, R. and Kobow, K. and Bhattarai, N. and Pérez-Palma, E. and Hamer, H. and Brandner, S. and Rössler, K. and Bien, C.G. and Kalbhenn, T. and Pieper, T. and Hartlieb, T. and Butler, E. and Genovese, G. and Becker, K. and Altmüller, J. and Niestroj, L.M. and Ferguson, L. and Busch, R.M. and Nürnberg, P. and Najm, I. and Blümcke, I. and Lal, D.
Brain 146 (4): 1342-1356. April 2023

Mutations in TAF8 cause a neurodegenerative disorder.
Wong, K.M. and Jepsen, W.M. and Efthymiou, S. and Salpietro, V. and Sanchez-Castillo, M. and Yip, J. and Kriouile, Y. and Diegmann, S. and Dreha-Kulaczewski, S. and Altmüller, J. and Thiele, H. and Nürnberg, P. and Toosi, M.B. and Akhondian, J. and Ghayoor Karimiani, E. and Hummel-Abmeier, H. and Huppke, B. and Houlden, H. and Gärtner, J. and Maroofian, R. and Huppke, P.
Brain 145 (9): 3022-3034. September 2022

Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
Smajić, S. and Prada-Medina, C.A. and Landoulsi, Z. and Ghelfi, J. and Delcambre, S. and Dietrich, C. and Jarazo, J. and Henck, J. and Balachandran, S. and Pachchek, S. and Morris, C.M. and Antony, P. and Timmermann, B. and Sauer, S. and Pereira, S.L. and Schwamborn, J.C. and May, P. and Grünewald, A. and Spielmann, M.
Brain 145 (3): 964-978. March 2022

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Petrou, P. and Kassis, I. and Levin, N. and Paul, F. and Backner, Y. and Benoliel, T. and Oertel, F.C. and Scheel, M. and Hallimi, M. and Yaghmour, N. and Hur, T.B. and Ginzberg, A. and Levy, Y. and Abramsky, O. and Karussis, D.
Brain 143 (12): 3574-3588. December 2020

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Dietrich, M. and Koska, V. and Hecker, C. and Göttle, P. and Hilla, A.M. and Heskamp, A. and Lepka, K. and Issberner, A. and Hallenberger, A. and Baksmeier, C. and Steckel, J. and Balk, L. and Knier, B. and Korn, T. and Havla, J. and Martínez-Lapiscina, E.H. and Solà-Valls, N. and Manogaran, P. and Olbert, E.D. and Schippling, S. and Cruz-Herranz, A. and Yiu, H. and Button, J. and Caldito, N.G. and von Gall, C. and Mausberg, A.K. and Stettner, M. and Zimmermann, H.G. and Paul, F. and Brandt, A.U. and Küry, P. and Goebels, N. and Aktas, O. and Berndt, C. and Saidha, S. and Green, A.J. and Calabresi, P.A. and Fischer, D. and Hartung, H.P. and Albrecht, P.
Brain 143 (4): 1127-1142. April 2020

Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain.
Van Steenwinckel, J. and Schang, A.L. and Krishnan, M.L. and Degos, V. and Delahaye-Duriez, A. and Bokobza, C. and Csaba, Z. and Verdonk, F. and Montané, A. and Sigaut, S. and Hennebert, O. and Lebon, S. and Schwendimann, L. and Le Charpentier, T. and Hassan-Abdi, R. and Ball, G. and Aljabar, P. and Saxena, A. and Holloway, R.K. and Birchmeier, W. and Baud, O. and Rowitch, D. and Miron, V. and Chretien, F. and Leconte, C. and Besson, V.C. and Petretto, E.G. and Edwards, A.D. and Hagberg, H. and Soussi-Yanicostas, N. and Fleiss, B. and Gressens, P.
Brain 142 (12): 3806-3833. December 2019

Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
Niturad, C.E. and Lev, D. and Kalscheuer, V.M. and Charzewska, A. and Schubert, J. and Lerman-Sagie, T. and Kroes, H.Y. and Oegema, R. and Traverso, M. and Specchio, N. and Lassota, M. and Chelly, J. and Bennett-Back, O. and Carmi, N. and Koffler-Brill, T. and Iacomino, M. and Trivisano, M. and Capovilla, G. and Striano, P. and Nawara, M. and Rzonca, S. and Fischer, U. and Bienek, M. and Jensen, C. and Hu, H. and Thiele, H. and Altmüller, J. and Krause, R. and May, P. and Becker, F. and Balling, R. and Biskup, S. and Haas, S.A. and Nürnberg, P. and van Gassen, K.L.I. and Lerche, H. and Zara, F. and Maljevic, S. and Leshinsky-Silver, E.
Brain 140 (11): 2879-2894. 1 November 2017

Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
Kreye, J. and Wenke, N.K. and Chayka, M. and Leubner, J. and Murugan, R. and Maier, N. and Jurek, B. and Ly, L.T. and Brandl, D. and Rost, B.R. and Stumpf, A. and Schulz, P. and Radbruch, H. and Hauser, A.E. and Pache, F. and Meisel, A. and Harms, L. and Paul, F. and Dirnagl, U. and Garner, C. and Schmitz, D. and Wardemann, H. and Prüss, H.
Brain 139 (10): 2641-2652. 1 October 2016

Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.
Bartus, K. and Galino, J. and James, N.D. and Hernandez-Miranda, L.R. and Dawes, J.M. and Fricker, F.R. and Garratt, A.N. and McMahon, S.B. and Ramer, M.S. and Birchmeier, C. and Bennett, D.L.H. and Bradbury, E.J.
Brain 139 (Pt 5): 1394-1416. May 2016

CHD2 variants are a risk factor for photosensitivity in epilepsy.
Galizia, E.C. and Myers, C.T. and Leu, C. and de Kovel, C.G.F. and Afrikanova, T. and Cordero-Maldonado, M.L. and Martins, T.G. and Jacmin, M. and Drury, S. and Krishna Chinthapalli, V. and Muhle, H. and Pendziwiat, M. and Sander, T. and Ruppert, A.K. and Møller, R.S. and Thiele, H. and Krause, R. and Schubert, J. and Lehesjoki, A.E. and Nürnberg, P. and Lerche, H. and Palotie, A. and Coppola, A. and Striano, S. and Gaudio, L.D. and Boustred, C. and Schneider, A.L. and Lench, N. and Jocic-Jakubi, B. and Covanis, A. and Capovilla, G. and Veggiotti, P. and Piccioli, M. and Parisi, P. and Cantonetti, L. and Sadleir, L.G. and Mullen, S.A. and Berkovic, S.F and Stephani, U. and Helbig, I. and Crawford, A.D. and Esguerra, C.V. and Kasteleijn-Nolst Trenité, D.G.A. and Koeleman, B.P.C. and Mefford, H.C. and Scheffer, I.E. and Sisodiya, S.M.
Brain 138 (5): 1198-1207. May 2015

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
Vos, S.J.B. and Verhey, F. and Froelich, L. and Kornhuber, J. and Wiltfang, J. and Maier, W. and Peters, O. and Ruether, E. and Nobili, F. and Morbelli, S. and Frisoni, G.B. and Drzezga, A. and Didic, M. and van Berckel, B.N.M. and Simmons, A. and Soininen, H. and Kloszewska, I. and Mecocci, P. and Tsolaki, M. and Vellas, B. and Lovestone, S. and Muscio, C. and Herukka, S.K. and Salmon, E. and Bastin, C. and Wallin, A. and Nordlund, A. and de Mendonca, A. and Silva, D. and Santana, I. and Lemos, R. and Engelborghs, S. and Van der Mussele, S. and Freund-Levi, Y. and Wallin, A.K. and Hampel, H. and van der Flier, W. and Scheltens, P. and Visser, P.J.
Brain 138 (Pt 5): 1327-1338. May 2015

New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.
Hoppmann, N. and Graetz, C. and Paterka, M. and Poisa-Beiro, L. and Larochelle, C. and Hasan, M. and Lill, C.M. and Zipp, F. and Siffrin, V.
Brain 138 (Pt 4): 902-917. April 2015

Axonal neuregulin 1 is a rate limiting but not essential factor for nerve remyelination.
Fricker, F.R. and Antunes-Martins, A. and Galino, J. and Paramsothy, R. and La Russa, F. and Perkins, J. and Goldberg, R. and Brelstaff, J. and Zhu, N. and McMahon, S.B. and Orengo, C. and Garratt, A.N. and Birchmeier, C. and Bennett, D.L.
Brain 136 (Pt 7): 2279-2297. July 2013

Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Jolivel, V. and Luessi, F. and Masri, J. and Kraus, S.H.P. and Hubo, M. and Poisa-Beiro, L. and Klebow, S. and Paterka, M. and Yogev, N. and Tumani, H. and Furlan, R. and Siffrin, V. and Jonuleit, H. and Zipp, F. and Waisman, A.
Brain 136 (4): 1048-1066. 1 April 2013

Essential role of interleukin-6 in post-stroke angiogenesis.
Gertz, K. and Kronenberg, G. and Kaelin, R.E. and Baldinger, T. and Werner, C. and Balkaya, M. and Eom, G.D. and Hellmann-Regen, J. and Kroeber, J. and Miller, K.R. and Lindauer, U. and Laufs, U. and Dirnagl, U. and Heppner, F.L. and Endres, M.
Brain 135 (Pt 6): 1964-1980. June 2012

Irregular RNA splicing curtails postsynaptic gephyrin in the cornu ammonis of patients with epilepsy.
Foerstera, B. and Belaidi, A.A. and Juettner, R. and Bernert, C. and Tsokos, M. and Lehmann, T.N. and Horn, P. and Dehnicke, C. and Schwarz, G. and Meier, J.C.
Brain 133 (Pt12): 3778-3794. December 2010

Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.
Chirasani, S.R. and Sternjak, A. and Wend, P. and Momma, S. and Campos, B. and Herrmann, I.M. and Graf, D. and Mitsiadis, T. and Herold-Mende, C. and Besser, D. and Synowitz, M. and Kettenmann, H. and Glass, R.
Brain 133 (Pt 7): 1961-1972. July 2010

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte, S. and von Ahsen, N. and Kruse, N. and Huber, B. and Winkelmann, A. and Zettl, U.K. and Starck, M. and Koenig, N. and Tellez, N. and Doerr, J. and Paul, F. and Zipp, F. and Luehder, F. and Koepsell, H. and Pannek, H. and Montalban, X. and Gold, R. and Chan, A.
Brain 132 (Pt 9): 2517-2530. September 2009

Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization.
Siffrin, V. and Brandt, A.U. and Radbruch, H. and Herz, J. and Boldakowa, N. and Leuenberger, T. and Werr, J. and Hahner, A. and Schulze-Topphoff, U. and Nitsch, R. and Zipp, F.
Brain 132 (5): 1247-1258. May 2009

Perivascular spaces - MRI marker of inflammatory activity in the brain?
Wuerfel, J. and Haertle, M. and Waiczies, H. and Tysiak, E. and Bechmann, I. and Wernecke, K.D. and Zipp, F. and Paul, F.
Brain 131 (Pt 9): 2332-2340. September 2008

Epilepsy and mental retardation limited to females: an under-recognized disorder.
Scheffer, I.E. and Turner, S.J. and Dibbens, L.M. and Bayly, M.A. and Friend, K. and Hodgson, B. and Burrows, L. and Shaw, M. and Chen, W. and Ullmann, R. and Ropers, H.H. and Szepetowski, P. and Haan, E. and Mazarib, A. and Afawi, Z. and Neufeld, M.Y. and Andrews, P.I. and Wallace, G. and Kivity, S. and Lev, D. and Lerman-Sagie, T. and Derry, C.P. and Korczyn, A.D. and Gecz, J. and Mulley, J.C. and Berkovic, S.F.
Brain 131 (4): 918-927. April 2008

Pathological consequences of VCP mutations on human striated muscle.
Huebbers, C.U. and Clemen, C.S. and Kesper, K. and Boeddrich, A. and Hofmann, A. and Kaemaeraeinen, O. and Tolksdorf, K. and Stumpf, M. and Reichelt, J. and Roth, U. and Krause, S. and Watts, G. and Kimonis, V. and Wattjes, M.P. and Reimann, J. and Thal, D.R. and Biermann, K. and Evert, B.O. and Lochmueller, H. and Wanker, E.E. and Schoser, B.G. and Noegel, A.A. and Schroeder, R.
Brain 130 (2): 381-393. 1 February 2007

The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.
Sliwa, M. and Markovic, D. and Gabrusiewicz, K. and Synowitz, M. and Glass, R. and Zawadzka, M. and Wesolowska, A. and Kettenmann, H. and Kaminska, B.
Brain 130 (Pt. 2): 476-489. 1 February 2007

A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions.
Gommans, I.M.P. and Davis, M. and Saar, K. and Lammens, M. and Mastaglia, F. and Lamont, P. and Van Duijnhoven, G. and Ter Laak, H.J. and Reis, A. and Vogels, O.J.M. and Laing, N. and van Engelen, B.G.M. and Kremer, H.
Brain 126 (7): 1545-1551. July 2003

Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery.
Filippi, M. and Yousry, T. and Baratti, C. and Horsfield, M.A. and Mammi, S. and Becker, C. and Voltz, R. and Spuler, S. and Campi, A. and Reiser, M.F. and Comi, G.
Brain 119 (4): 1349-1355. August 1996

Review

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
Filippi, M. and Preziosa, P. and Banwell, B.L. and Barkhof, F. and Ciccarelli, O. and De Stefano, N. and Geurts, J.J.G. and Paul, F. and Reich, D.S. and Toosy, A.T. and Traboulsee, A. and Wattjes, M.P. and Yousry, T.A. and Gass, A. and Lubetzki, C. and Weinshenker, B.G. and Rocca, M.A.
Brain 142 (7): 1858-1875. July 2019

Letter

Aggressive multiple sclerosis - a matter of measurement and timing.
Ellenberger, D. and Flachenecker, P. and Fneish, F. and Frahm, N. and Hellwig, K. and Paul, F. and Stahmann, A. and Warnke, C. and Rommer, P.S. and Zettl, U.K.
Brain 143 (11): e97. November 2020

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
Brandt, A.U. and Oberwahrenbrock, T. and Ringelstein, M. and Young, K.L. and Tiede, M. and Hartung, H.P. and Martin, R. and Aktas, O. and Paul, F. and Schippling, S.
Brain 134 (Pt 11): e193. November 2011